DHAI (DIH Holding US) FCF Margin %: -26.79% (As of Mar. 2025)


What is DIH Holding US FCF Margin %?

DIH Holding US DHAI FCF Margin % is -26.79% as of Mar. 2025.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. DIH Holding US's Free Cash Flow for the three months ended in Mar. 2025 was $-3.39 Mil. DIH Holding US's Revenue for the three months ended in Mar. 2025 was $12.65 Mil. Therefore, DIH Holding US's FCF Margin % for the quarter that ended in Mar. 2025 was -26.79%.

As of today, DIH Holding US's current FCF Yield % is -468,000.00%.

The historical rank and industry rank for DIH Holding US's FCF Margin % or its related term are showing as below:

DHAI' s FCF Margin % Range Over the Past 10 Years
Min: -7.54   Med: 0   Max: 0
Current: -7.54

DHAI's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -0.03 vs DHAI: -7.54

DIH Holding US FCF Margin % Related Terms

DIH Holding US FCF Margin % Historical Data

* Premium members only.

The historical data trend for DIH Holding US's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DIH Holding US FCF Margin % Chart

DIH Holding US Annual Data
Trend Mar22 Mar23 Mar24 Mar25
FCF Margin %
-3.49 10.95 7.74 -7.44

DIH Holding US Quarterly Data
Mar22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -13.87 1.59 4.41 -26.79

DHAI vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, DIH Holding US's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DIH Holding US FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DIH Holding US's FCF Margin % distribution charts can be found below:

* The bar in red indicates where DIH Holding US's FCF Margin % falls into.


DIH Holding US FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

DIH Holding US's FCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-4.68/62.864
=-7.44 %

DIH Holding US's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-3.388/12.648
=-26.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -26.79% mean?
DIH Holding US (DHAI) has a FCF Margin % of -26.79% as of Mar. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DIH Holding US and its competitors.
Is DIH Holding US's FCF Margin % too high?
DIH Holding US's current FCF Margin % is -26.79%.
How does DIH Holding US's FCF Margin % compare to ABT and SYK?
DIH Holding US's FCF Margin % of -26.79% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DIH Holding US and its competitors. DIH Holding US's current FCF Margin % is -26.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current FCF Margin % of -26.79%. The current FCF Margin % is -26.79%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For DIH Holding US (DHAI), the current FCF Margin % is -26.79% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DIH Holding US Business Description

Address 77 Accord Park Drive, Suite D-1, Norwell, MA, USA, 02061
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.